[Results of anti-estrogen therapy in metastatic breast cancer (preliminary results). Part II].
D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011388:Prolactin / Q000097:blood; D011960:Receptors, Estrogen / Q000032:analysis; D012075:Remission, Spontaneous; D013629:Tamoxifen / Q000627:therapeutic use*; D013973:Thyrotropin-Releasing Hormone / Q000097:blood
D011960:Receptors, Estrogen; D013629:Tamoxifen; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin
Ergebnisse der Antiöstrogen-Therapie bei metastasierendem Mammakarzinom (Vorlüfige resultate). Teil II.